IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14)

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/ATVBAHA.117.310626PMID 29371247PMCID PMC5823772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury

  2017cited by this paper
• Mitochondrial ROS, uncoupled from ATP synthesis, determine endothelial activation for both physiological recruitment of patrolling cells and pathological recruitment of inflammatory cells.

  2017cited by this paper
• Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

  2017cited by this paper
• IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector, and blocker in cardiovascular diseases.

  2017cited by this paper
• Lysophospholipids and their G protein-coupled receptors in atherosclerosis.

  2016cited by this paper
• Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets—“Sand Out and Gold Stays”

  2016cited by this paper
• Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation—Novel Paradigm and Therapeutic Potential

  2016cited by this paper
• Caspase-1 Plays a Critical Role in Accelerating Chronic Kidney Disease-Promoted Neointimal Hyperplasia in the Carotid Artery

  2016cited by this paper
• Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair.

  2016cited by this paper
• MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease

  2016cited by this paper
• Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation

  2016cited by this paper
• IL-35 improves Treg-mediated immune suppression in atherosclerotic mice

  2016cited by this paper
• How leukocytes cross the vascular endothelium

  2015cited by this paper
• Human tolerogenic dendritic cells produce IL‐35 in the absence of other IL‐12 family members

  2015cited by this paper
• Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy

  2015cited by this paper
• Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells.

  2015cited by this paper
• Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 Pathway

  2015cited by this paper
• Pathological conditions re-shape physiological Tregs into pathological Tregs

  2015cited by this paper
• Assessment of some demographic risk factors associated with diaphyseal humeral fractures among Nigerians

  2015cited by this paper
• Anti-inflammatory therapies for atherosclerosis

  2015cited by this paper
• Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway*

  2015cited by this paper
• IL-35 and Autoimmunity: a Comprehensive Perspective

  2015cited by this paper
• Chronic kidney disease alters vascular smooth muscle cell phenotype.

  2015cited by this paper
• IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

  2014cited by this paper
• A quantitative multiplexed mass spectrometry assay for studying the kinetic of residue-specific histone acetylation.

  2014cited by this paper
• Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction- a novel mechanism for maintaining vascular function

  2014cited by this paper
• Hyperhomocysteinemia Potentiates Hyperglycemia-Induced Inflammatory Monocyte Differentiation and Atherosclerosis

  2014cited by this paper
• Quantitating the Specificity and Selectivity of Gcn5-Mediated Acetylation of Histone H3

  2013cited by this paper
• FOXP3: genetic and epigenetic implications for autoimmunity.

  2013cited by this paper
• Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

  2013cited by this paper
• Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.

  2013cited by this paper
• IL-35 Is a Novel Responsive Anti-inflammatory Cytokine — A New System of Categorizing Anti-inflammatory Cytokines

  2012cited by this paper
• Acetyl-CoA Carboxylase Regulates Global Histone Acetylation*♦

  2012cited by this paper
• The composition and signaling of the IL-35 receptor are unconventional

  2012cited by this paper
• Redox Regulation of Mitochondrial Function

  2012cited by this paper
• Endothelial progenitor cells in atherosclerosis.

  2012cited by this paper
• A role for mitochondria in NLRP3 inflammasome activation

  2011cited by this paper
• Recent Advances on the Role of Cytokines in Atherosclerosis

  2011cited by this paper
• Chromatin remodeling in cardiovascular development and physiology.

  2011cited by this paper
• Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)

  2011cited by this paper
• Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity.

  2010cited by this paper
• Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells

  2009cited by this paper
• Bioengineered corneas for transplantation and in vitro toxicology.

  2009cited by this paper
• Function of Mitochondrial Stat3 in Cellular Respiration

  2009cited by this paper
• Innate and adaptive immunity in atherosclerosis

  2009cited by this paper
• Expression of TCTP antisense in CD25(high) regulatory T cells aggravates cuff-injured vascular inflammation.

  2009cited by this paper
• Interleukin‐35: odd one out or part of the family?

  2008cited by this paper
• IL-33 reduces the development of atherosclerosis

  2008cited by this paper
• Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

  2008cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• The inhibitory cytokine IL-35 contributes to regulatory T-cell function

  2007cited by this paper
• Natural regulatory T cells control the development of atherosclerosis in mice

  2006cited by this paper
• The role of transforming growth factor-β in atherosclerosis

  2006cited by this paper
• The role of transforming growth factor-beta in atherosclerosis.

  2006cited by this paper
• Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.

  2005cited by this paper
• Epigenetics in human disease and prospects for epigenetic therapy

  2004cited by this paper
• Interleukin-10 Deficiency Increases Atherosclerosis, Thrombosis, and Low-density Lipoproteins in Apolipoprotein E Knockout Mice

  2003cited by this paper
• Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability

  2001cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• Uremic toxin receptor NR1H3 contributes to hyperlipidemia- and chronic kidney disease-accelerated vascular inflammation, which is partially suppressed by novel YBX2 anti-ROS pathway

  2025cites this paper
• Genetic variant rs2243115 of the IL-12/IL-35 pathway contributes to the risk of coronary artery disease

  2025cites this paper
• Accelerating inflammatory resolution in humans to improve endothelial function and vascular health: Targeting the non-canonical pathway for NO

  2025cites this paper
• New Types of Post-Translational Modification of Proteins in Cardiovascular Diseases

  2025cites this paper
• Systematic Review of Interleukin-35 in Endothelial Dysfunction: A New Target for Therapeutic Intervention

  2025cites this paper
• H3K14la drives endothelial dysfunction in sepsis‐induced ARDS by promoting SLC40A1/transferrin‐mediated ferroptosis

  2025cites this paper
• The recombinant IL-35 and anti-Ebi3 antibody administration before implantation modulate immune regulation and fetal outcomes in an abortion-prone mouse model

  2025cites this paper
• H3K14: A histone site closely related to diseases

  2025cites this paper
• Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers - Targeting PERK as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer.

  2024cites this paper
• Innate immunity of vascular smooth muscle cells contributes to two-wave inflammation in atherosclerosis, twin-peak inflammation in aortic aneurysms and trans-differentiation potential into 25 cell types

  2024cites this paper
• Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases

  2024cites this paper
• Decreased Expression of IL‐35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia

  2024cites this paper
• Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression

  2024cites this paper
• Interplay of Reactive Oxygen Species (ROS) and Epigenetic Remodelling in Cardiovascular Diseases Pathogenesis: A Contemporary Perspective.

  2024cites this paper
• Cellular and molecular biology of posttranslational modifications in cardiovascular disease.

  2024cites this paper
• A new paradigm in intracellular immunology: Mitochondria emerging as leading immune organelles

  2024cites this paper
• The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus.

  2024cites this paper
• Breakthroughs in road mapping IL-35 mediated immunotherapy for type-1 and autoimmune diabetes mellitus.

  2024cites this paper
• The Effects of Nicotine and Cannabinoids on Cytokines.

  2024cites this paper
• Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages

  2023cites this paper
• Evaluation of IL-6, IL-25 & IL-35 in the COVID 19 Patients and their Correlation to Demography Data in the Symptomatic Patients.

  2023cites this paper
• Mitochondria-Targeted Uncouplers Decrease Inflammatory Reactions in Endothelial Cells by Enhancing Methylation of the ICAM1 Gene Promoter.

  2023cites this paper
• Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis

  2023influential citation
• Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

  2023cites this paper
• Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring

  2023cites this paper
• Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity

  2023cites this paper
• The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells

  2023cites this paper
• Mechanoresponsive Drug Delivery Systems for Vascular Diseases.

  2023cites this paper
• Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis

  2022cites this paper
• IL‐35 enhances angiogenic effects of small extracellular vesicles in breast cancer

  2022cites this paper
• 29 m6A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation – 102 Transcriptomic Dataset Analyses

  2022cites this paper
• Aorta in Pathologies May Function as an Immune Organ by Upregulating Secretomes for Immune and Vascular Cell Activation, Differentiation and Trans-Differentiation—Early Secretomes may Serve as Drivers for Trained Immunity

  2022cites this paper
• Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD)

  2022cites this paper
• Chronic Exposure to the Combination of Cigarette Smoke and Morphine Decreases CD4+ Regulatory T Cell Numbers by Reprogramming the Treg Cell Transcriptome

  2022cites this paper
• Expression of anti and pro‐inflammatory genes in human endothelial cells activated by 25‐hydroxycholesterol: A comparison of rivaroxaban and dabigatran

  2022cites this paper
• Epigenetics-mediated pathological alternations and their potential in antiphospholipid syndrome diagnosis and therapy.

  2022cites this paper
• Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis.

  2022cites this paper
• Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling Pathway

  2022cites this paper
• An appraisal of polymers of DES technology and their impact on drug release kinetics

  2022cites this paper
• Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics

  2022cites this paper
• Cigarette Smoke Modulates Inflammation and Immunity via Reactive Oxygen Species-Regulated Trained Immunity and Trained Tolerance Mechanisms

  2022cites this paper
• Cigarette Smoke and Morphine Promote Treg Plasticity to Th17 via Enhancing Trained Immunity

  2022cites this paper
• Editorial: Endothelial cells as innate immune cells

  2022cites this paper
• Role of interleukin‐35 in cardiovascular diseases

  2022cites this paper
• USP14-mediated NLRC5 upregulation inhibits endothelial cell activation and inflammation in atherosclerosis.

  2022cites this paper
• Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways

  2022influential citation
• Rumen-protected glucose supplementation alters fecal microbiota and its metabolic profiles in early lactation dairy cows

  2022cites this paper
• Increasing Upstream Chromatin Long-Range Interactions May Increasing Upstream Chromatin Long-Range Interactions May Favor Induction of Circular RNAs in LysoPC-Activated Human Favor Induction of Circular RNAs in LysoPC-Activated Human Aortic Endothelial Cells. Aortic Endothelial Cells.

  2022cites this paper
• Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases

  2021cites this paper
• IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms

  2021cites this paper
• Procaspase-1 patrolled to the nucleus of proatherogenic lipid LPC-activated human aortic endothelial cells induces ROS promoter CYP1B1 and strong inflammation

  2021cites this paper
• Interleukin-35 inhibits lipopolysaccharide-induced endothelial cell activation by downregulating inflammation and apoptosis.

  2021cites this paper
• Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation

  2021cites this paper
• Organelle Crosstalk Regulators Are Regulated in Diseases, Tumors, and Regulatory T Cells: Novel Classification of Organelle Crosstalk Regulators

  2021cites this paper
• Lysophosphatidylcholine induces oxidative stress in human endothelial 1 cells via NOX 5 activation-implications in atherosclerosis 2 3

  2021cites this paper
• Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism

  2021influential citation
• Tissue Treg Secretomes and Transcription Factors Shared With Stem Cells Contribute to a Treg Niche to Maintain Treg-Ness With 80% Innate Immune Pathways, and Functions of Immunosuppression and Tissue Repair

  2021cites this paper
• Lysophosphatidylcholine induces oxidative stress in  human endothelial cells via NOX5 activation - implications in atherosclerosis.

  2021cites this paper
• IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment

  2021cites this paper
• Canonical Secretomes, Innate Immune Caspase-1-, 4/11-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity via ROS Pathways

  2021cites this paper
• The Role of Histone Protein Acetylation in Regulating Endothelial Function

  2021cites this paper
• Ultrasound May Suppress Tumor Growth, Inhibit Inflammation, and Establish Tolerogenesis by Remodeling Innatome via Pathways of ROS, Immune Checkpoints, Cytokines, and Trained Immunity/Tolerance

  2021cites this paper
• Interleukin 35 protects cardiomyocytes following ischemia/reperfusion-induced apoptosis via activation of mitochondrial STAT3.

  2021cites this paper
• Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrosis

  2020cites this paper
• Host immune response in chronic hepatitis C infection: involvement of cytokines and inflammasomes

  2020cites this paper
• Endocytic Adaptors in Cardiovascular Disease

  2020cites this paper
• Th17/Treg Imbalance and Atherosclerosis

  2020cites this paper
• End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression

  2020cites this paper
• Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges

  2020cites this paper
• Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.

  2020cites this paper
• Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ)

  2020cites this paper
• Approaching Inflammation Paradoxes—Proinflammatory Cytokine Blockages Induce Inflammatory Regulators

  2020cites this paper
• ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes

  2020cites this paper
• Metabolic Reprogramming in Immune Response and Tissue Inflammation

  2020cites this paper
• Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactions.

  2020cites this paper
• Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice

  2020cites this paper
• Beyond Macrophages and T Cells: B Cells and Immunoglobulins Determine the Fate of the Atherosclerotic Plaque

  2020influential citation
• Vascular Endothelial Cells and Innate Immunity.

  2020cites this paper
• rIL‐35 prevents murine transfusion‐related acute lung injury by inhibiting the activation of endothelial cells

  2020cites this paper
• Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications.

  2020cites this paper
• Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers.

  2020cites this paper
• RECENT HIGHLIGHTS OF ATVB

  2019cites this paper
• Increasing Upstream Chromatin Long–Range Interactions May Favor Induction of Circular RNAs in LysoPC-Activated Human Aortic Endothelial Cells

  2019cites this paper
• Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice

  2019cites this paper
• Experimental Data-Mining Analyses Reveal New Roles of Low-Intensity Ultrasound in Differentiating Cell Death Regulatome in Cancer and Non-cancer Cells via Potential Modulation of Chromatin Long-Range Interactions

  2019cites this paper
• Metabolic Biomarkers In Midtrimester Maternal Plasma Can Accurately Predict Adverse Pregnancy Outcome in Patients with SLE

  2019cites this paper
• Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells

  2019cites this paper
• Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics

  2019cites this paper
• Proton leak regulates mitochondrial reactive oxygen species generation in endothelial cell activation and inflammation - A novel concept.

  2019cites this paper
• Updates on Approaches for Studying Atherosclerosis.

  2019cites this paper
• The Clinical Potential of IL-12/IL-35 in Treating Chemotherapy Drug-induced Cardiac Injury

  2018cites this paper
• Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice

  2018cites this paper
• Molecular mechanisms and genetic regulation in atherosclerosis

  2018cites this paper
• Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice

  2018cites this paper
• Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation

  2018cites this paper
• DNA Checkpoint and Repair Factors Are Nuclear Sensors for Intracellular Organelle Stresses—Inflammations and Cancers Can Have High Genomic Risks

  2018cites this paper